Sven Michel
Overview
Explore the profile of Sven Michel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riera-Tur I, Hinterdobler J, Maaske A, Sadewasser A, Schell M, Sekar J, et al.
Nucleic Acid Ther
. 2024 Jul;
34(5):257-271.
PMID: 39018509
Early characterization of the immunostimulatory potential of therapeutic antisense oligonucleotides (ASOs) is crucial. At present, little is known about the toll-like receptor 9 (TLR9)-mediated immunostimulatory potential of third-generation locked nucleic...
2.
Lu T, Zhang C, Li Z, Wei Y, Sadewasser A, Yan Y, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(4):1044-1059.
PMID: 38909634
Background: The Spike protein mutation severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to decreased protective effect of various vaccines and mAbs, suggesting that blocking SARS-CoV-2 infection by targeting host...
3.
Kirschner J, Michel S, Becker R, Stiebitz O, Hommel H, Schulz R, et al.
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511659
Due to the high heterogeneity in outcome measures after total hip arthroplasty (THA), the prospective observational study investigated the relationships between symmetry-based (SBMs), performance-based (PBMs), and functional outcome measures in...
4.
Kaufmann B, de Los Reyes Jimenez M, Booshehri L, Onyuru J, Leszczynska A, Uri A, et al.
J Immunol
. 2023 May;
211(2):287-294.
PMID: 37256266
Antisense oligonucleotides (ASOs) are a novel therapeutic strategy that targets a specific gene and suppresses its expression. The cryopyrin-associated periodic syndromes (CAPS) are a spectrum of autoinflammatory diseases characterized by...
5.
Fernandez-Rodriguez L, Cianciaruso C, Bill R, Trefny M, Klar R, Kirchhammer N, et al.
J Immunother Cancer
. 2023 May;
11(5).
PMID: 37208130
Background: Although immune checkpoint inhibitors have been a breakthrough in clinical oncology, these therapies fail to produce durable responses in a significant fraction of patients. This lack of long-term efficacy...
6.
Jahnke S, Cruysen C, Prill R, Kittmann F, Pflug N, Albert J, et al.
Healthcare (Basel)
. 2023 Feb;
11(4).
PMID: 36833047
A randomized crossover trial was designed to investigate the influence of muscle activation and strength on functional stability/control of the knee joint, to determine whether bilateral imbalances still occur six...
7.
Ciesla E, Suliga E, Kaducakova H, Michel S, Izova M, Simockova V, et al.
Nutrients
. 2022 Nov;
14(22).
PMID: 36432579
Purpose: The aim of this study was to assess the reproducibility and reliability of the KomPAN questionnaire among two groups of university students from Germany and Slovakia. Methods: A total...
8.
Deng M, Kutrolli E, Sadewasser A, Michel S, Joibari M, Jaschinski F, et al.
J Lipid Res
. 2022 Jun;
63(7):100237.
PMID: 35667416
Angiopoietin-like 4 (ANGPTL4) is an important regulator of plasma triglyceride (TG) levels and an attractive pharmacological target for lowering plasma lipids and reducing cardiovascular risk. Here, we aimed to study...
9.
Shahzad K, Fatima S, Al-Dabet M, Gadi I, Khawaja H, Ambreen S, et al.
J Am Soc Nephrol
. 2021 Sep;
32(12):3066-3079.
PMID: 34479965
Background: Maladaptive endoplasmic reticulum stress signaling in diabetic kidney disease (DKD) is linked to increased glomerular and tubular expression of the cell-death-promoting transcription factor C/EBP homologous protein (CHOP). Here, we...
10.
Michel S, Klar R, Jaschinski F
Nucleic Acid Ther
. 2021 Jul;
31(6):427-435.
PMID: 34251864
Locked nucleic acid-modified antisense oligonucleotides (ASOs) can achieve strongly different degrees of target knockdown despite having similar biophysical properties and 100% homology with their target. The determinants for this observation...